{"product_id":"cardiac-care-9781119117780","title":"Cardiac Care","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eList of Contributors xiv\u003c\/p\u003e \u003cp\u003eForeword xvii\u003c\/p\u003e \u003cp\u003ePreface xviii\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart I Knowledge for Practice \u003c\/b\u003e\u003cb\u003e1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Mechanics of the Cardiovascular System \u003c\/b\u003e\u003cb\u003e3\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBrendan Greaney and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 3\u003c\/p\u003e \u003cp\u003eBasic Heart Anatomy 3\u003c\/p\u003e \u003cp\u003eReferences 11\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 Regulation of Cardiac and Vascular Function \u003c\/b\u003e\u003cb\u003e12\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBrendan Greaney and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 12\u003c\/p\u003e \u003cp\u003eCentral Nervous System Regulation of the Cardiovascular System 12\u003c\/p\u003e \u003cp\u003eVasomotor Control 14\u003c\/p\u003e \u003cp\u003eBaroreceptors 14\u003c\/p\u003e \u003cp\u003eGravity and Venous Return 14\u003c\/p\u003e \u003cp\u003eChemoreceptors 15\u003c\/p\u003e \u003cp\u003eHumoral Control 16\u003c\/p\u003e \u003cp\u003eElectrolytes 18\u003c\/p\u003e \u003cp\u003eConclusion 19\u003c\/p\u003e \u003cp\u003eReferences 20\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Cardiac Electrophysiology \u003c\/b\u003e\u003cb\u003e21\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBrendan Greaney and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 21\u003c\/p\u003e \u003cp\u003eCardiac Cells 21\u003c\/p\u003e \u003cp\u003eThe Action Potential 22\u003c\/p\u003e \u003cp\u003eThe Action Potential in Non-Pacemaker Cells 22\u003c\/p\u003e \u003cp\u003eThe Cardiac Conduction System 24\u003c\/p\u003e \u003cp\u003eThe Electrocardiogram 26\u003c\/p\u003e \u003cp\u003eConclusion 26\u003c\/p\u003e \u003cp\u003eReferences 28\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 The Coronary Circulation \u003c\/b\u003e\u003cb\u003e29\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eBrendan Greaney and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 29\u003c\/p\u003e \u003cp\u003eThe Coronary Circulation 29\u003c\/p\u003e \u003cp\u003eThe Left Main Coronary Artery 30\u003c\/p\u003e \u003cp\u003eThe Left Anterior Descending Artery 31\u003c\/p\u003e \u003cp\u003eThe Left Circumflex Artery 31\u003c\/p\u003e \u003cp\u003eThe Right Coronary Artery 31\u003c\/p\u003e \u003cp\u003eCollateral Circulation 32\u003c\/p\u003e \u003cp\u003eMicrovascular Circulation 32\u003c\/p\u003e \u003cp\u003eCoronary Venous Circulation 32\u003c\/p\u003e \u003cp\u003eReferences 33\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart II Cardiovascular Disease Assessment \u003c\/b\u003e\u003cb\u003e35\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Risk Factors for Cardiovascular Disease \u003c\/b\u003e\u003cb\u003e37\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia and Angela Hartley\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 37\u003c\/p\u003e \u003cp\u003eAbsolute Risk 37\u003c\/p\u003e \u003cp\u003eClassification of Risk Factors for CVD 38\u003c\/p\u003e \u003cp\u003eBiomedical Risk Factors 39\u003c\/p\u003e \u003cp\u003eBehavioural Risk Factors 44\u003c\/p\u003e \u003cp\u003ePsychosocial Risk Factors 46\u003c\/p\u003e \u003cp\u003eConclusion 48\u003c\/p\u003e \u003cp\u003eReferences 49\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Cardiovascular Assessment \u003c\/b\u003e\u003cb\u003e52\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eJan Keenan and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 52\u003c\/p\u003e \u003cp\u003eHealth History 53\u003c\/p\u003e \u003cp\u003ePhysical Examination 54\u003c\/p\u003e \u003cp\u003eConclusion 65\u003c\/p\u003e \u003cp\u003eReferences 66\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Laboratory Tests Used in Acute Cardiac Assessment \u003c\/b\u003e\u003cb\u003e67\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDavid Barrett and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 67\u003c\/p\u003e \u003cp\u003eGeneric Laboratory Tests 67\u003c\/p\u003e \u003cp\u003eCommon Laboratory Tests Used in Cardiovascular Disease 67\u003c\/p\u003e \u003cp\u003eLaboratory Specimen Collection 73\u003c\/p\u003e \u003cp\u003eConclusion 74\u003c\/p\u003e \u003cp\u003eReferences 74\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Diagnostic Procedures \u003c\/b\u003e\u003cb\u003e76\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSteven A. Unger and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 76\u003c\/p\u003e \u003cp\u003ePurpose of Diagnostic Tests 76\u003c\/p\u003e \u003cp\u003ePreparation for Diagnostic Procedures 77\u003c\/p\u003e \u003cp\u003eMedical Imaging Tests 78\u003c\/p\u003e \u003cp\u003eElectrocardiography Tests 93\u003c\/p\u003e \u003cp\u003ePhysiological Testing 93\u003c\/p\u003e \u003cp\u003eStress Testing 95\u003c\/p\u003e \u003cp\u003eConclusion 100\u003c\/p\u003e \u003cp\u003eReferences 100\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart III Detection and Management of Heart Rhythm Disturbances \u003c\/b\u003e\u003cb\u003e103\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Electrocardiogram (ECG) Interpretation \u003c\/b\u003e\u003cb\u003e105\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eCarol Oldroyd and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 105\u003c\/p\u003e \u003cp\u003eNormal Sequence of Depolarisation and Repolarisation 106\u003c\/p\u003e \u003cp\u003eTheoretical Basis of Electrocardiography 107\u003c\/p\u003e \u003cp\u003eECG Leads 107\u003c\/p\u003e \u003cp\u003eThe Cardiac Axis 110\u003c\/p\u003e \u003cp\u003eDetermination of Heart Rate and Electrocardiographic Intervals 111\u003c\/p\u003e \u003cp\u003eChamber Enlargement 112\u003c\/p\u003e \u003cp\u003eBundle Branch Block 114\u003c\/p\u003e \u003cp\u003eECG Changes Related to Myocardial Ischaemia and Infarction 117\u003c\/p\u003e \u003cp\u003eMyocardial Infarction 118\u003c\/p\u003e \u003cp\u003eThe ST-Segment 118\u003c\/p\u003e \u003cp\u003ePericarditis 118\u003c\/p\u003e \u003cp\u003eKey Point 119\u003c\/p\u003e \u003cp\u003eT-Wave Abnormalities 120\u003c\/p\u003e \u003cp\u003eQ-Waves 120\u003c\/p\u003e \u003cp\u003eSite of Infarction 121\u003c\/p\u003e \u003cp\u003eIncremental ECG Leads 121\u003c\/p\u003e \u003cp\u003eObtaining a 12-Lead ECG 122\u003c\/p\u003e \u003cp\u003eEquipment Preparation 122\u003c\/p\u003e \u003cp\u003ePatient Preparation 123\u003c\/p\u003e \u003cp\u003eConclusion 125\u003c\/p\u003e \u003cp\u003eReferences 126\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Cardiac Monitoring in the Clinical Setting \u003c\/b\u003e\u003cb\u003e128\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia and Carol Oldroyd\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 128\u003c\/p\u003e \u003cp\u003eECG Monitoring Systems and Lead Formats 129\u003c\/p\u003e \u003cp\u003eThree-Electrode Monitoring Systems 129\u003c\/p\u003e \u003cp\u003eFive-Electrode Monitoring Systems 129\u003c\/p\u003e \u003cp\u003eTwelve-Lead (10 Electrode) Monitoring Systems 130\u003c\/p\u003e \u003cp\u003eTelemetry Monitoring Systems 131\u003c\/p\u003e \u003cp\u003eIndications for Arrhythmia Monitoring in the Clinical Setting 132\u003c\/p\u003e \u003cp\u003eAlarm Fatigue 134\u003c\/p\u003e \u003cp\u003eReferences 138\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Arrhythmias \u003c\/b\u003e\u003cb\u003e139\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 139\u003c\/p\u003e \u003cp\u003eMechanisms of Arrhythmia Generation 139\u003c\/p\u003e \u003cp\u003eEctopy, Aberrancy and Escape Beats 145\u003c\/p\u003e \u003cp\u003eSinus Dysrhythmias 147\u003c\/p\u003e \u003cp\u003eAtrial Dysrhythmias 150\u003c\/p\u003e \u003cp\u003eVentricular Rhythms and Tachyarrhythmias 156\u003c\/p\u003e \u003cp\u003eHeart Block Related to Atrioventricular Nodal Conduction 162\u003c\/p\u003e \u003cp\u003eConclusion 169\u003c\/p\u003e \u003cp\u003eReferences 170\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Assessment and Management of Cardiac Rhythm Disturbances (Arrhythmias) \u003c\/b\u003e\u003cb\u003e173\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eCarolyn E. Shepherd, Jenny Tagney, and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 173\u003c\/p\u003e \u003cp\u003eAssessment 173\u003c\/p\u003e \u003cp\u003eTaking a Clinical History 174\u003c\/p\u003e \u003cp\u003ePhysical Examination 174\u003c\/p\u003e \u003cp\u003eDiagnostic Investigations 177\u003c\/p\u003e \u003cp\u003eSmartphone Technology 180\u003c\/p\u003e \u003cp\u003eImaging 180\u003c\/p\u003e \u003cp\u003eDiagnosis of Cardiac Channelopathies 182\u003c\/p\u003e \u003cp\u003eTreatment Strategies for Arrhythmia 183\u003c\/p\u003e \u003cp\u003ePharmacological Therapy 183\u003c\/p\u003e \u003cp\u003eElectrical (Direct Current) Synchronised Cardioversion 187\u003c\/p\u003e \u003cp\u003eDefibrillation 188\u003c\/p\u003e \u003cp\u003eCardiac Ablation 189\u003c\/p\u003e \u003cp\u003eTemporary Pacing 190\u003c\/p\u003e \u003cp\u003eTemporary Transvenous Pacing 190\u003c\/p\u003e \u003cp\u003eTranscutaneous Pacing 190\u003c\/p\u003e \u003cp\u003eOther Forms of Temporary Pacing 191\u003c\/p\u003e \u003cp\u003eImplantable Cardiac Devices 191\u003c\/p\u003e \u003cp\u003eImplantable Pacemakers 191\u003c\/p\u003e \u003cp\u003eImplantable Cardioverter Defibrillators 193\u003c\/p\u003e \u003cp\u003eImplantation Procedure for Cardiac Devices 194\u003c\/p\u003e \u003cp\u003eImplantable Device Complications 196\u003c\/p\u003e \u003cp\u003ePractical Advice for Patients Following Device Implantation 197\u003c\/p\u003e \u003cp\u003eAdvanced Nursing Roles in Arrhythmia Management 199\u003c\/p\u003e \u003cp\u003eReferences 199\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart IV Detection and Management of Acute Coronary Syndromes \u003c\/b\u003e\u003cb\u003e205\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Pathogenesis of Acute Coronary Syndromes \u003c\/b\u003e\u003cb\u003e207\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia and John D. Horowitz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 207\u003c\/p\u003e \u003cp\u003eAcute Coronary Syndrome 207\u003c\/p\u003e \u003cp\u003eAtherosclerosis 208\u003c\/p\u003e \u003cp\u003eEndothelial Dysfunction 208\u003c\/p\u003e \u003cp\u003eInflammation 208\u003c\/p\u003e \u003cp\u003ePlaque Rupture and Thrombosis 209\u003c\/p\u003e \u003cp\u003ePathological Characteristics of Myocardial Ischaemia and Infarction 210\u003c\/p\u003e \u003cp\u003eConclusion 213\u003c\/p\u003e \u003cp\u003eReferences 214\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Chest Pain Assessment \u003c\/b\u003e\u003cb\u003e216\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia, John F. Beltrame, and Jan Keenan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 216\u003c\/p\u003e \u003cp\u003eBackground 216\u003c\/p\u003e \u003cp\u003eCoronary Heart Disease 217\u003c\/p\u003e \u003cp\u003eAngina Pectoris 217\u003c\/p\u003e \u003cp\u003eAcute Coronary Syndrome 218\u003c\/p\u003e \u003cp\u003eMyocardial Infarction with Non-Obstructive Coronaries (MINOCA) 220\u003c\/p\u003e \u003cp\u003ePresentation with Chest Pain in the Emergency Department 220\u003c\/p\u003e \u003cp\u003eTypical Clinical Presentation of Ischaemic Chest Pain 221\u003c\/p\u003e \u003cp\u003eAtypical Presentations 222\u003c\/p\u003e \u003cp\u003eChest Pain Assessment 223\u003c\/p\u003e \u003cp\u003ePhysical Examination in ACS Patients 225\u003c\/p\u003e \u003cp\u003eThe 12‑lead Electrocardiogram in ACS 225\u003c\/p\u003e \u003cp\u003eTroponin 227\u003c\/p\u003e \u003cp\u003eClinical Assessment and Risk Stratification in ACS 227\u003c\/p\u003e \u003cp\u003eConclusion 228\u003c\/p\u003e \u003cp\u003eReferences 228\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Risk Stratification in Acute Coronary Syndromes \u003c\/b\u003e\u003cb\u003e231\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDeborah Wright, Cassandra Ryan, and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 231\u003c\/p\u003e \u003cp\u003eBackground 231\u003c\/p\u003e \u003cp\u003eThe Nature of Risk in Cardiovascular Disease 233\u003c\/p\u003e \u003cp\u003eRisk Stratification for Differentiating Between Likely Cardiac-Related Pain and Non-Cardiac Pain 233\u003c\/p\u003e \u003cp\u003eRisk Stratification Tools 235\u003c\/p\u003e \u003cp\u003eThe HEART Score 235\u003c\/p\u003e \u003cp\u003eRule-in\/Rule-out Strategies for NSTE-ACS 236\u003c\/p\u003e \u003cp\u003eConclusion 237\u003c\/p\u003e \u003cp\u003eReferences 238\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Management of Acute Coronary Syndromes \u003c\/b\u003e\u003cb\u003e240\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eChristopher J. Zeitz, Ian D. Jones, and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 240\u003c\/p\u003e \u003cp\u003eBackground 240\u003c\/p\u003e \u003cp\u003eConsiderations in Nursing Care of the Patient with Acute Coronary Syndrome 241\u003c\/p\u003e \u003cp\u003eST Elevation Acute Coronary Syndrome (STE-ACS) 242\u003c\/p\u003e \u003cp\u003eST-segment Myocardial Infarction (STEMI) 242\u003c\/p\u003e \u003cp\u003eIschaemic ECG Abnormalities not Meeting STEMI Criteria 245\u003c\/p\u003e \u003cp\u003eCardiac Biomarkers in STEMI 245\u003c\/p\u003e \u003cp\u003ePrinciples of Reperfusion Strategies 245\u003c\/p\u003e \u003cp\u003eMechanical Reperfusion 246\u003c\/p\u003e \u003cp\u003eRole of the Nurse when Caring for a Patient Receiving Thrombolysis 248\u003c\/p\u003e \u003cp\u003eComplications of STEMI 249\u003c\/p\u003e \u003cp\u003eNon-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS) 252\u003c\/p\u003e \u003cp\u003eConvalescence and Secondary Prevention 253\u003c\/p\u003e \u003cp\u003eConclusion 254\u003c\/p\u003e \u003cp\u003eReferences 255\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Discharge Planning and Convalescence \u003c\/b\u003e\u003cb\u003e257\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eDavid R. Thompson, Patricia M. Davidson, and Rosemary A. Webster\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 257\u003c\/p\u003e \u003cp\u003eHospitalisation 257\u003c\/p\u003e \u003cp\u003ePatient and Partner Reactions and Needs after an Acute Cardiac Event 258\u003c\/p\u003e \u003cp\u003eDischarge Planning 258\u003c\/p\u003e \u003cp\u003eHigh-Risk Groups 260\u003c\/p\u003e \u003cp\u003eConvalescence 261\u003c\/p\u003e \u003cp\u003ePromoting Self-Care and Self-Management in the Convalescent Phase 263\u003c\/p\u003e \u003cp\u003eCommon Concerns of Partners and Family Members 265\u003c\/p\u003e \u003cp\u003eFacilitating Convalescence 265\u003c\/p\u003e \u003cp\u003eHome-Based Services 266\u003c\/p\u003e \u003cp\u003eNurse-Led Clinics 266\u003c\/p\u003e \u003cp\u003eCommunity Health Workers 266\u003c\/p\u003e \u003cp\u003eInformation Technology 267\u003c\/p\u003e \u003cp\u003eNursing Strategies to Promote Convalescence 267\u003c\/p\u003e \u003cp\u003ePalliative Care 267\u003c\/p\u003e \u003cp\u003eConclusion 267\u003c\/p\u003e \u003cp\u003eReferences 268\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Prevention Strategies in Cardiovascular Disease \u003c\/b\u003e\u003cb\u003e272\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRosemary A. Webster, Patricia M. Davidson, Praba Rabasse, and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 272\u003c\/p\u003e \u003cp\u003ePrevention Strategies 272\u003c\/p\u003e \u003cp\u003ePrimary Prevention in Cardiovascular Disease 273\u003c\/p\u003e \u003cp\u003eSecondary Prevention in Cardiovascular Disease 273\u003c\/p\u003e \u003cp\u003eTarget Population for Secondary Prevention 274\u003c\/p\u003e \u003cp\u003eCardiac Rehabilitation 274\u003c\/p\u003e \u003cp\u003eAssessment and Short-Term Monitoring 276\u003c\/p\u003e \u003cp\u003eLifestyle\/Behavioural Modification 276\u003c\/p\u003e \u003cp\u003ePsychosocial Risk Factors 283\u003c\/p\u003e \u003cp\u003eMedication Adherence 283\u003c\/p\u003e \u003cp\u003eRecovery and Longer-Term Maintenance 284\u003c\/p\u003e \u003cp\u003eConclusion 285\u003c\/p\u003e \u003cp\u003eReferences 285\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart V Cardiac Arrest \u003c\/b\u003e\u003cb\u003e289\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Sudden Cardiac Death \u003c\/b\u003e\u003cb\u003e291\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePete Gregory and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 291\u003c\/p\u003e \u003cp\u003eBackground 292\u003c\/p\u003e \u003cp\u003eBurden of Disease 292\u003c\/p\u003e \u003cp\u003eRisk Factors for Sudden Cardiac Death 293\u003c\/p\u003e \u003cp\u003eScreening in the General Population for Risk of Sudden Cardiac Death 294\u003c\/p\u003e \u003cp\u003eMechanisms of Sudden Cardiac Death 294\u003c\/p\u003e \u003cp\u003eSudden Cardiac Death in Structural Heart Disease 296\u003c\/p\u003e \u003cp\u003eCardiomyopathies and Sudden Cardiac Death 297\u003c\/p\u003e \u003cp\u003eInherited Primary Arrhythmia Syndromes 298\u003c\/p\u003e \u003cp\u003eSudden Cardiac Death Related to Special Populations 300\u003c\/p\u003e \u003cp\u003eImpact of Sudden Cardiac Death on Families and Loved Ones 300\u003c\/p\u003e \u003cp\u003eConclusion 303\u003c\/p\u003e \u003cp\u003eReferences 303\u003c\/p\u003e \u003cp\u003e\u003cb\u003e20 Pre-hospital Management of Cardiac Emergencies \u003c\/b\u003e\u003cb\u003e306\u003cbr\u003e\u003c\/b\u003e\u003ci\u003ePete Gregory and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 306\u003c\/p\u003e \u003cp\u003eIntroduction 307\u003c\/p\u003e \u003cp\u003eHazards to the Victim and Rescuer 308\u003c\/p\u003e \u003cp\u003eScene Safety 308\u003c\/p\u003e \u003cp\u003eRisks to the Rescuer 308\u003c\/p\u003e \u003cp\u003eResuscitation During the COVID-19 Pandemic 308\u003c\/p\u003e \u003cp\u003eRisks to the Victim 309\u003c\/p\u003e \u003cp\u003eCircumstances that make OHCA Different from Hospital Resuscitation 310\u003c\/p\u003e \u003cp\u003ePauses in Chest Compressions 312\u003c\/p\u003e \u003cp\u003eAutomated External Defibrillation 312\u003c\/p\u003e \u003cp\u003ePractical Factors Affecting Defibrillation 312\u003c\/p\u003e \u003cp\u003eChest Compressions Following Defibrillation 313\u003c\/p\u003e \u003cp\u003eConclusion 313\u003c\/p\u003e \u003cp\u003eReferences 314\u003c\/p\u003e \u003cp\u003e\u003cb\u003e21 In-Hospital Resuscitation \u003c\/b\u003e\u003cb\u003e317\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia and Melanie Rushton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 317\u003c\/p\u003e \u003cp\u003ePrevention: Systems for Identifying Patients at Risk of Cardiac Arrest 319\u003c\/p\u003e \u003cp\u003eRecommended Strategies for the Prevention of Avoidable Cardiac Arrest 320\u003c\/p\u003e \u003cp\u003eRescuer Safety 323\u003c\/p\u003e \u003cp\u003eEquipment 325\u003c\/p\u003e \u003cp\u003eBasic Life Support 325\u003c\/p\u003e \u003cp\u003eAdvanced Life Support 326\u003c\/p\u003e \u003cp\u003ePost-Resuscitation Care 327\u003c\/p\u003e \u003cp\u003eAudit and Data Collection 328\u003c\/p\u003e \u003cp\u003eConclusion 328\u003c\/p\u003e \u003cp\u003eReferences 329\u003c\/p\u003e \u003cp\u003e\u003cb\u003e22 Ethical Issues in Resuscitation and end of Life Care \u003c\/b\u003e\u003cb\u003e332\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia and Annabella S. Gloster\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 332\u003c\/p\u003e \u003cp\u003eGuiding Ethical Principles in Resuscitation 332\u003c\/p\u003e \u003cp\u003eMedical Futility 333\u003c\/p\u003e \u003cp\u003eResuscitation Orders 334\u003c\/p\u003e \u003cp\u003eAdvanced Care Planning and Advanced Directives 335\u003c\/p\u003e \u003cp\u003eWithdrawal of Treatment 336\u003c\/p\u003e \u003cp\u003eWitnessed Resuscitation 337\u003c\/p\u003e \u003cp\u003eOrgan Donation 337\u003c\/p\u003e \u003cp\u003eTraining and Research with the Newly Dead 338\u003c\/p\u003e \u003cp\u003eConclusion 338\u003c\/p\u003e \u003cp\u003eReferences 339\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart VI Chronic Cardiac Conditions \u003c\/b\u003e\u003cb\u003e341\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003e23 Heart Failure \u003c\/b\u003e\u003cb\u003e343\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eSalimah Hassan, Christopher Nicholson, Robyn Lotto, and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 343\u003c\/p\u003e \u003cp\u003eDefinition of Heart Failure 344\u003c\/p\u003e \u003cp\u003eHeart Failure Terminology 344\u003c\/p\u003e \u003cp\u003eEpidemiology 346\u003c\/p\u003e \u003cp\u003eSignificance 347\u003c\/p\u003e \u003cp\u003ePrognosis 347\u003c\/p\u003e \u003cp\u003eAetiology 347\u003c\/p\u003e \u003cp\u003eDiagnosis 348\u003c\/p\u003e \u003cp\u003eInvestigations 353\u003c\/p\u003e \u003cp\u003eChronic Heart Failure Management 354\u003c\/p\u003e \u003cp\u003eComorbidities in Heart Failure 361\u003c\/p\u003e \u003cp\u003eSystems of Care 364\u003c\/p\u003e \u003cp\u003eEnd of Life 365\u003c\/p\u003e \u003cp\u003eAcute Heart Failure 365\u003c\/p\u003e \u003cp\u003eConclusion 367\u003c\/p\u003e \u003cp\u003eReferences 367\u003c\/p\u003e \u003cp\u003e\u003cb\u003e24 Congenital Heart Disease \u003c\/b\u003e\u003cb\u003e372\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eRobyn Lotto, Christopher Nicholson, and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 372\u003c\/p\u003e \u003cp\u003eBackground 372\u003c\/p\u003e \u003cp\u003eEpidemiology 372\u003c\/p\u003e \u003cp\u003eRisk Factors for the Development of Congenital Heart Disease 373\u003c\/p\u003e \u003cp\u003eEmbryology 374\u003c\/p\u003e \u003cp\u003eCongenital Heart Disease Classification 375\u003c\/p\u003e \u003cp\u003eCHD with Shunt Between Systemic and Pulmonary Circulation 376\u003c\/p\u003e \u003cp\u003eAcyanotic CHD 378\u003c\/p\u003e \u003cp\u003eAcyanotic CHD with Outflow Obstruction 381\u003c\/p\u003e \u003cp\u003eCyanotic CHD 383\u003c\/p\u003e \u003cp\u003eDextrocardia 386\u003c\/p\u003e \u003cp\u003eConclusion 393\u003c\/p\u003e \u003cp\u003eReferences 394\u003c\/p\u003e \u003cp\u003e\u003cb\u003e25 Structural Heart Disease \u003c\/b\u003e\u003cb\u003e399\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eChristopher Nicholson, Salimah Hassan, Robyn Lotto, and Angela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 399\u003c\/p\u003e \u003cp\u003eValvular Heart Disease 399\u003c\/p\u003e \u003cp\u003eCardiomyopathy 404\u003c\/p\u003e \u003cp\u003eOther Forms of Cardiomyopathy 407\u003c\/p\u003e \u003cp\u003eThe Multidisciplinary Team Caring for Patients with Acquired Structural Heart Disease 408\u003c\/p\u003e \u003cp\u003eConclusion 408\u003c\/p\u003e \u003cp\u003eReferences 409\u003c\/p\u003e \u003cp\u003e\u003cb\u003e26 Takotsubo Syndrome \u003c\/b\u003e\u003cb\u003e412\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 412\u003c\/p\u003e \u003cp\u003eBackground 412\u003c\/p\u003e \u003cp\u003eEpidemiology 413\u003c\/p\u003e \u003cp\u003ePrognosis 413\u003c\/p\u003e \u003cp\u003ePathophysiology 415\u003c\/p\u003e \u003cp\u003eTriggers for TTS 416\u003c\/p\u003e \u003cp\u003eClinical Presentation 417\u003c\/p\u003e \u003cp\u003eWall Motion Abnormalities in TTS 419\u003c\/p\u003e \u003cp\u003eCardiac Biomarkers 420\u003c\/p\u003e \u003cp\u003eDiagnostic Criteria 420\u003c\/p\u003e \u003cp\u003eDiagnostic Imaging 420\u003c\/p\u003e \u003cp\u003eClinical Course 421\u003c\/p\u003e \u003cp\u003eManagement 422\u003c\/p\u003e \u003cp\u003eConclusion 423\u003c\/p\u003e \u003cp\u003eReferences 424\u003c\/p\u003e \u003cp\u003e\u003cb\u003e27 Non-Obstructive Coronary Artery Disease (\u003ci\u003eMINOCA\/INOCA\u003c\/i\u003e) \u003c\/b\u003e\u003cb\u003e428\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eAngela M. Kucia and John F. Beltrame\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eOverview 428\u003c\/p\u003e \u003cp\u003eMyocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) 428\u003c\/p\u003e \u003cp\u003eManagement 430\u003c\/p\u003e \u003cp\u003eConclusion 434\u003c\/p\u003e \u003cp\u003eReferences 435\u003c\/p\u003e \u003cp\u003eIndex 437\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406990877015,"sku":"9781119117780","price":38.9,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781119117780.jpg?v=1730497807","url":"https:\/\/bookcurl.com\/products\/cardiac-care-9781119117780","provider":"Book Curl","version":"1.0","type":"link"}